Atomic AI Company

Atomic AI is a developing the cutting-edge fusion of machine learning and structural biology to unlock RNA drug discovery.
Industry: Early Drug Development
Headquarters: South San Francisco, California, United States
Founded Date: 2020-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 14
Total Funding: 42000000
Last Funding Date: 2023-01-25
Last Funding Type: Series A

Visit Website
info@atomic.ai
https://twitter.com/AtomicAICo
Register and Claim Ownership